| 790468 |
BMC CANCER |
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma |
2022-01-03 |
10.1186/s12885-021-09028-4 |
Chen Xi, Kong Haiying, Luo Linxiang, Han Shuiyun, Lei Tao, Yu Haifeng, Guo Na, Li Cong, Peng Shuailing, Dong Xiaowu, Yang Haiyan, Wu Meijuan |
| 790467 |
BMC CANCER |
Application of protection motivation theory (PMT) on skin cancer preventive behaviors amongst primary school students in rural areas of Fasa city-Iran |
2022-01-03 |
10.1186/s12885-021-09142-3 |
Khani Jeihooni Ali, Bashti Somayeh, Erfanian Bahareh, Ostovarfar Jeyran, Afzali Hasirini Pooyan |
| 790466 |
BMC CANCER |
Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery |
2022-01-03 |
10.1186/s12885-021-09101-y |
Chen Chen, Yi Wei, Zeng Zhi-fan, Wang Qiao-xuan, Jiang Wu, Gao Yuan-hong, Chang Hui |
| 790465 |
BMC CANCER |
Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women |
2022-01-03 |
10.1186/s12885-021-09074-y |
Esposito Maria Valeria, Fosso Bruno, Nunziato Marcella, Casaburi Giorgio, D’Argenio Valeria, Calabrese Alessandra, D’Aiuto Massimiliano, Botti Gerardo, Pesole Graziano, Salvatore Francesco |
| 790464 |
BMC CANCER |
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment |
2022-01-03 |
10.1186/s12885-021-09146-z |
Rosenberg Ari J., Izumchenko Evgeny, Pearson Alexander, Gooi Zhen, Blair Elizabeth, Karrison Theodore, Juloori Aditya, Ginat Daniel, Cipriani Nicole, Lingen Mark, Sloane Hillary, Edelstein Daniel L., Keyser Kirsten, Fredebohm Johannes, Holtrup Frank, Jones Frederick S., Haraf Daniel, Agrawal Nishant, Vokes Everett E. |
| 790463 |
BMC CANCER |
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer |
2022-01-03 |
10.1186/s12885-021-09138-z |
Park Soo Jin, Chang Suk-Joon, Suh Dong Hoon, Kong Tae Wook, Song Heekyoung, Kim Tae Hun, Kim Jae-Weon, Kim Hee Seung, Lee Sung-Jong |
| 790462 |
BMC CANCER |
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer |
2022-01-03 |
10.1186/s12885-021-09095-7 |
Douglas Julia E., Liu Suyu, Ma Junsheng, Wolff Robert A., Pant Shubham, Maitra Anirban, Tamm Eric P., Bhosale Priya, Katz Matthew H. G., Varadhachary Gauri R., Koay Eugene J. |
| 790461 |
BMC CANCER |
Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study |
2022-01-03 |
10.1186/s12885-021-09113-8 |
Kasahara Kenta, Enomoto Masanobu, Udo Ryutaro, Tago Tomoya, Mazaki Junichi, Ishizaki Tetsuo, Yamada Tesshi, Nagakawa Yuichi, Katsumata Kenji, Tsuchida Akihiko |
| 790460 |
BMC CANCER |
Targeting CD33 for acute myeloid leukemia therapy |
2022-01-03 |
10.1186/s12885-021-09116-5 |
Liu Jingjing, Tong Jiayin, Yang Haiping |
| 790459 |
BMC CANCER |
Integration of breast cancer care in a middle-income country: learning from Suandok Breast Cancer Network (SBCN) |
2022-01-03 |
10.1186/s12885-021-09153-0 |
Chitapanarux Imjai, Onchan Wimrak, Wongmaneerung Panchaporn, Somwangprasert Areewan, Bunyoo Nongnuch, Ditsatham Chagkrit, Watcharachan Kirati, Charoentum Chaiyut, Sripan Patumrat, Chumachote Ausreeya, Maneesai Puttachart |
